关注
Andrew B. Benowitz
Andrew B. Benowitz
在 gsk.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Tunneling nanotubes and gap junctions–their role in long-range intercellular communication during development, health, and disease conditions
J Ariazi, A Benowitz, V De Biasi, ML Den Boer, S Cherqui, H Cui, ...
Frontiers in molecular neuroscience 10, 333, 2017
2202017
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
A Mares, AH Miah, IED Smith, M Rackham, AR Thawani, J Cryan, ...
Communications biology 3 (1), 140, 2020
1722020
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
MB Pappalardi, K Keenan, M Cockerill, WA Kellner, A Stowell, C Sherk, ...
Nature cancer 2 (10), 1002-1017, 2021
1632021
The PROTACtable genome
M Schneider, CJ Radoux, A Hercules, D Ochoa, I Dunham, LP Zalmas, ...
Nature reviews Drug discovery 20 (10), 789-797, 2021
1622021
Stereochemistry of the core structure of the mycolactones
AB Benowitz, S Fidanze, PLC Small, Y Kishi
Journal of the American Chemical Society 123 (21), 5128-5129, 2001
1072001
Total synthesis of the mycolactones
F Song, S Fidanze, AB Benowitz, Y Kishi
Organic letters 4 (4), 647-650, 2002
822002
Discovery and characterisation of highly cooperative FAK‐degrading PROTACs
RP Law, J Nunes, C Chung, M Bantscheff, K Buda, H Dai, JP Evans, ...
Angewandte Chemie International Edition 60 (43), 23327-23334, 2021
802021
Structural insights into PROTAC-mediated degradation of Bcl-xL
C Chung, H Dai, E Fernandez, CP Tinworth, I Churcher, J Cryan, ...
ACS Chemical Biology 15 (9), 2316-2323, 2020
682020
Design and synthesis of a competent pyrrolinone− peptide hybrid ligand for the class II major histocompatibility complex protein HLA-DR1
AB Smith, AB Benowitz, PA Sprengeler, J Barbosa, MC Guzman, ...
Journal of the American Chemical Society 121 (40), 9286-9298, 1999
551999
Selective CDK6 degradation mediated by cereblon, VHL, and novel IAP-recruiting PROTACs
NA Anderson, J Cryan, A Ahmed, H Dai, GA McGonagle, C Rozier, ...
Bioorganic & Medicinal Chemistry Letters 30 (9), 127106, 2020
492020
In vitro and in vivo induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor
AG Gilmartin, A Groy, ER Gore, C Atkins, ER Long, MN Montoute, Z Wu, ...
Haematologica 106 (7), 1979, 2021
482021
Total synthesis of mycolactones A and B
F Song, S Fidanze, AB Benowitz, Y Kishi
Tetrahedron 63 (26), 5739-5753, 2007
432007
A second-generation synthesis of scalemic 3, 5, 5-trisubstituted pyrrolin-4-ones: Incorporation of functionalized amino acid side-chains
AB Smith III, AB Benowitz, DA Favor, PA Sprengeler, R Hirschmann
Tetrahedron letters 38 (22), 3809-3812, 1997
391997
Discovery and characterization of a class of pyrazole inhibitors of bacterial undecaprenyl pyrophosphate synthase
N Concha, J Huang, X Bai, A Benowitz, P Brady, LSC Grady, LH Kryn, ...
Journal of Medicinal Chemistry 59 (15), 7299-7304, 2016
372016
Design, Synthesis, and Evaluation of a Pyrrolinone− Peptide Hybrid Ligand for the Class II MHC Protein HLA-DR1
AB Smith, AB Benowitz, MC Guzman, PA Sprengeler, R Hirschmann, ...
Journal of the American Chemical Society 120 (48), 12704-12705, 1998
341998
The therapeutic potential of PROTACs
AB Benowitz, KL Jones, JD Harling
Expert Opinion on Therapeutic Patents 31 (1), 1-24, 2021
312021
Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase
S Howard, N Amin, AB Benowitz, E Chiarparin, H Cui, X Deng, ...
ACS Medicinal Chemistry Letters 4 (12), 1208-1212, 2013
302013
Design, synthesis, and binding affinities of pyrrolinone-based somatostatin mimetics
AB Smith, AK Charnley, EF Mesaros, O Kikuchi, W Wang, A Benowitz, ...
Organic Letters 7 (3), 399-402, 2005
302005
Peptide deformylase inhibitors
D Qin, B Norton, X Liao, AN Knox, Y Fang, J Lee, JC Dreabit, ...
232009
The crystal structure of a pyrrolinone− peptide hybrid ligand bound to the human class II MHC protein HLA-DR1
KH Lee, GL Olson, DR Bolin, AB Benowitz, PA Sprengeler, AB Smith, ...
Journal of the American Chemical Society 122 (35), 8370-8375, 2000
222000
系统目前无法执行此操作,请稍后再试。
文章 1–20